SPAC Daily: DWAC Hit as Grand Jury Details are Digested

by | Jun 27, 2022

Once trading at $175, DWAC may be coming back to reality and shareholders will feel the sting.

Digital World Acquisition (DWAC) is again the star of the SPAC show as it released details on its grand jury subpoenas. The stock dropped -9.56% on the day down to $25.16. DWAC also announced that Bruce Garelick (CSO of Rocket One) was stepping down as a director. While DWAC is still trading far above the $10 NAV for SPACs, investors that have gotten caught up in the somewhat irrational exuberance while it was trading towards its high will be feeling real pain today. For more details, Bloomberg covers it well here.

DWAC, the Trump-tied SPAC’s wild ride continues

Elsewhere in SPACS

  • FYI, there are still around 590 pre-deal SPACs searching for targets and only 9 new deals announced in June so far. And, there are over 115 SPACs with announced deals trying to get their deals over the line. Our June monthly SPAC Market Update will cover numbers in more depth, but it’s clear that June hasn’t delivered any positive surprises regarding the SPAC market’s health.
  • NORTHERN LIGHTS ACQUISITION (NLIT) adjourned again until June 28th for the vote on their deal with Safe Harbor Financial. This follows their reschedule from last week. NLIT ended the day up 16.5% at 9.26.
  • TUSCAN HOLDINGS CORP II (TCHCA) released details on their extension vote from last week. 39,400 shareholders redeemed and the extension was approved to December with an addition of $0.10 for the first 3 months and $0.033 / month thereafter. Note, around 84% of shareholders had already redeemed.
  • Agrico Acquisition (RICO) went to vote today, but we’re awaiting details.
  • EMERGE TECHNOLOGY ACQUISITION (ETAC) and VICKERS VANTAGE (VCKA) both have extension votes this week.
  • SPAC Rumor: Bloomberg has India’s JetSynthesis in talks with BurTech (BRKH)
  • ICYMI, we had a SPAC IPO on Friday: SK Growth Opportunities for $200M
  • Polestar (PSNY) (ex- GPPI) dropped -14.5% today and ended at $11.11. PSNY will be closely watched as many believe it to be a “real” EV company that could actually break the deSPAC curse, outperform for shareholders, and become a rival to Tesla. In the near term, shareholders should expect plenty of volatility.
  • Yotta Acquisition (YOTA) and Cartesian Growth II (RENE) both started trading separately today.
  • Iron Spark I (ISAA) declared a quarterly cash dividend of $0.05 per share. Payable July 15, 2022 to stockholders of record on July 8, 2022.

Know Who Drives Return

Objective, data-driven assessments for every public company director and officer.

SPAC Analytics & Database

Comprehensive research and analytics on every SPAC, sponsor, and deal. Real-time alerts, yields, red flags, filings, investors, and much more. API access to institutional grade SPAC database.

Monthly SPAC Review

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

SPAC Research & Analysis

Comera Life Sciences Debuts in the Red

Comera Life Sciences (CMRA), the maker of self-injectible biologics, deSPAC’d today, closing down 9%. An updated look at deSPAC count and redemption rates. And the rest of the day’s news in SPACs.

SPAC Deals on a Daily Double

Another 2 SPAC DAs today, offset by some liquidations. And the rest of the day’s news in SPACs.

Starting the Week with 2 DAs

Starting the week off with 2 DAs– oil & gas and battery tech. And the rest of the day’s news in SPACs.

Comera Gets Approval, with Over 98% Redemptions

Squeeze alert: OTRA approves its merger with Comera Life Sciences, albeit with some of highest redemptions we’ve seen in a while (98.4%). And the rest of the day’s news in SPACs.

Know Who Drives Return Podcast

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.